A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients. [electronic resource]
Producer: 20140815Description: 316-21 p. digitalISSN:- 2148-5607
- Adolescent
- Adult
- Aged
- Amoxicillin -- administration & dosage
- Anti-Bacterial Agents -- administration & dosage
- Bismuth -- administration & dosage
- Clarithromycin -- administration & dosage
- Drug Administration Schedule
- Drug Therapy, Combination
- Dyspepsia -- drug therapy
- Endoscopy, Digestive System
- Female
- Helicobacter Infections -- diagnosis
- Helicobacter pylori -- drug effects
- Histamine H2 Antagonists -- administration & dosage
- Humans
- Lansoprazole -- administration & dosage
- Male
- Middle Aged
- Prospective Studies
- Proton Pump Inhibitors -- administration & dosage
- Ranitidine -- administration & dosage
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.